Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Novavax Inc (NVAX)

Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,393,609
  • Shares Outstanding, K 160,185
  • Annual Sales, $ 983,710 K
  • Annual Income, $ -545,060 K
  • EBIT $ -301 M
  • EBITDA $ -260 M
  • 60-Month Beta 2.02
  • Price/Sales 1.41
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 84.83% ( -2.44%)
  • Historical Volatility 65.48%
  • IV Percentile 19%
  • IV Rank 16.13%
  • IV High 187.27% on 05/13/24
  • IV Low 65.13% on 05/09/24
  • Put/Call Vol Ratio 0.18
  • Today's Volume 7,105
  • Volume Avg (30-Day) 11,653
  • Put/Call OI Ratio 0.72
  • Today's Open Interest 322,126
  • Open Int (30-Day) 307,387

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.67
  • Number of Estimates 5
  • High Estimate -0.47
  • Low Estimate -0.85
  • Prior Year -1.44
  • Growth Rate Est. (year over year) +53.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.95 +9.37%
on 11/21/24
9.75 -10.77%
on 12/16/24
+0.64 (+7.94%)
since 11/20/24
3-Month
6.81 +27.75%
on 11/15/24
15.22 -42.84%
on 10/02/24
-4.21 (-32.61%)
since 09/20/24
52-Week
3.53 +146.29%
on 02/05/24
23.86 -63.54%
on 06/06/24
+3.79 (+77.19%)
since 12/20/23

Most Recent Stories

More News
Novavax Nabs $50M From First Sanofi Partnership Milestone: Retail Optimism Climbs

This milestone marks the first achievement since the partnership began in May, with the potential for Novavax to earn up to $300 million in additional milestones.

IBB : 132.73 (+1.16%)
VTI : 293.28 (+1.14%)
NVAX : 8.70 (+0.23%)
IWM : 221.92 (+0.94%)
2 Beaten-Down "Pandemic Stocks" to Consider for Contrarian Investors

Many companies that performed well in the early pandemic years have since fallen off the radar or at least have seen their shares drop substantially during the past three years. Telemedicine Teladoc Health...

TDOC : 9.44 (+5.24%)
NVAX : 8.70 (+0.23%)
SNY : 47.71 (+0.44%)
Novavax Stock Rises, Boosts Retail Sentiment On $200M Czech Plant Sale To Novo Nordisk

The sale is expected to reduce Novavax’s annual operating costs by $80 million.

NVO : 85.00 (-17.83%)
NVAX : 8.70 (+0.23%)
Is Biotech’s Bull Run Over? Examining Election Impacts

The biotech sector's breakout attempt post-election reversed sharply, with ETFs like IBB and XBI falling and invalidating the long-term bullish setup.

IBB : 132.73 (+1.16%)
NVAX : 8.70 (+0.23%)
MRNA : 39.39 (-0.43%)
XBI : 91.28 (+1.64%)
PFE : 26.36 (+2.29%)
Vaccine Stocks Slide, Psychedelic Stocks Surge After RFK Jr. HHS Nomination

Markets sent a clear message Friday following President-elect Donald Trump’s nomination of Robert F. Kennedy Jr. to head the Department of Health and Human Services (HHS). Vaccine stocks took a nosedive,...

CMPS : 3.97 (+1.28%)
PSIL : 10.62 (+1.15%)
ATAI : 1.1900 (unch)
AZN : 65.35 (+1.41%)
BVNRY : 8.9600 (+1.36%)
NVAX : 8.70 (+0.23%)
MRNA : 39.39 (-0.43%)
CYBN : 9.61 (+3.11%)
GSK : 33.60 (+0.51%)
PFE : 26.36 (+2.29%)
BNTX : 113.08 (+1.56%)
SNY : 47.71 (+0.44%)
Stock market today: Wall Street tumbles as the “Trump bump” fades and vaccine makers sink

U.S. stocks fell to their worst loss since Election Day as the boost that Wall Street got from last week’s victory for Donald Trump and a cut to interest rates by the Federal Reserve kept fading

AMAT : 163.59 (+1.33%)
ULTA : 430.01 (+1.06%)
$SPX : 5,930.85 (+1.09%)
POOL : 349.04 (+2.38%)
$DOWI : 42,840.26 (+1.18%)
BRK : 193.01 (-0.41%)
NVAX : 8.70 (+0.23%)
MRNA : 39.39 (-0.43%)
$IUXX : 21,289.15 (+0.85%)
PFE : 26.36 (+2.29%)
DPZ : 426.18 (-0.34%)
Stocks Tumble as Hawkish Fed and Strong US Economic News Boosts Bond Yields

The S&P 500 Index ($SPX ) (SPY ) today is down -1.17%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.72%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.03%. Stocks today extended Thursday’s...

AMAT : 163.59 (+1.33%)
AVGO : 220.79 (+1.13%)
$IUXX : 21,289.15 (+0.85%)
AMGN : 263.38 (+0.84%)
BNTX : 113.08 (+1.56%)
ASML : 705.68 (-0.64%)
DPZ : 426.18 (-0.34%)
ZNH25 : 108-310s (+0.33%)
GFS : 41.72 (+1.02%)
LLY : 767.76 (+1.35%)
LRCX : 71.79 (+0.81%)
AMD : 119.21 (+0.28%)
Stocks Retreat as Bond Yields Climb on a Hawkish Fed

The S&P 500 Index ($SPX ) (SPY ) today is down -0.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.34%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.36%. Stocks today are adding to...

KLAC : 629.37 (+1.16%)
AMAT : 163.59 (+1.33%)
ULTA : 430.01 (+1.06%)
$SPX : 5,930.85 (+1.09%)
$IUXX : 21,289.15 (+0.85%)
ASML : 705.68 (-0.64%)
BNTX : 113.08 (+1.56%)
DIS : 112.03 (+0.59%)
DPZ : 426.18 (-0.34%)
QQQ : 518.66 (+0.87%)
ZNH25 : 108-310s (+0.33%)
AAP : 43.52 (+3.72%)
Novavax Stock Slides As 2024 Revenue Cut Offsets Q3 Beat, Dampening Retail Confidence

Novavax CEO John Jacobs said the biopharma is looking to expand beyond COVID-19 and influenza.

NVAX : 8.70 (+0.23%)
IWM : 221.92 (+0.94%)
XBI : 91.28 (+1.64%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Novavax, Inc. is a biotechnology company engaged in developing innovative vaccines to prevent serious infectious diseases. The company is also developing proprietary immune stimulating saponin-based adjuvants, namely Matrix-M, which already enhanced immune responses and were well-tolerated in multiple...

See More

Key Turning Points

3rd Resistance Point 9.45
2nd Resistance Point 9.17
1st Resistance Point 8.94
Last Price 8.70
1st Support Level 8.42
2nd Support Level 8.13
3rd Support Level 7.90

See More

52-Week High 23.86
Fibonacci 61.8% 16.09
Fibonacci 50% 13.70
Fibonacci 38.2% 11.30
Last Price 8.70
52-Week Low 3.53

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar